Effectiveness of Cognitive Training in Older and Younger Adults
NCT ID: NCT06375681
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1600 participants
INTERVENTIONAL
2024-10-01
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the initial sessions, participants may be asked to complete two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab. Each set of sessions should be completed over a period of no more than 15 days. If asked to do these sessions, instructions will be given regarding the tasks to complete in these training sessions (which will be similar to some of the tasks you complete in the first two sessions, \~20 minutes) prior to these sessions.
After completing the first set of 10 sessions, participants will complete, either at home or in the lab, one session (\~75 minutes) of tasks similar to the first sessions. Participants who were not asked to complete the 20-minute sessions will complete another session two weeks after the first two 75-minute sessions in the same location as they completed the two 75-minute sessions.
Then, participants will complete the second set of ten 20-minute sessions, or wait for about two weeks for those not asked to complete the 20-minute sessions of cognitive tasks. After this, participants will complete two other sessions (\~75 minutes) in the same location as they completed the previous two 75-mintue sessions.
Finally, after a couple of weeks, participants will complete their two final testing sessions (\~45 minutes each) in the same location as they completed the previous two 75-mintue sessions.
The total duration of the study will be around 8 hours if not asked to complete the twenty 20-minute sessions, or 15 hours if asked to complete these sessions. The whole experiment runs over the course of 4 to 8 weeks.
\*To maintain scientific integrity, certain details of this study will not be shared until all data has been collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
The full description of the study's 9 arms will be registered after data collection is completed to preserve the scientific integrity of the study.
BASIC_SCIENCE
DOUBLE
Participants will be unaware of the experimental conditions.
Researchers and participants will be unaware (blinded) to the game conditions assigned to the participant, except for researchers in charge of supervising the training part of the study who will be aware what training the participant is undergoing.
More information on how this was achieved will be registered after data collection is completed to preserve the scientific integrity of the study.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Short Testing Group
Participants will go through 2 assessment sessions over 2-3 days (\~75 minutes each), followed by 1 session of 75 minutes about 2 weeks later, 2 further sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.
Visual and / or Auditory Cognitive Tasks (1)
Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.
Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.
Long Testing Group
Participants will go through 2 assessment sessions over 2-3 days (75 minutes each), followed by 10 sessions of cognitive tasks over 2 weeks, 1 session of 75 minutes about 2 weeks later, another 10 sessions of cognitive tasks over 2 weeks, then 2 sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.
Visual and / or Auditory Cognitive Tasks (1)
Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.
Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.
Visual and / or Auditory Cognitive Tasks (2)
Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab.
Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visual and / or Auditory Cognitive Tasks (1)
Seven sessions (\~45-75 minutes) of cognitive tasks in the lab.
Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.
Visual and / or Auditory Cognitive Tasks (2)
Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab.
Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No known neurological impairments
Exclusion Criteria
* History of seizures, focal brain lesion, or head injury with loss of consciousness in the past year
* Physical handicap (motor or perceptual) that would impede training procedures
* Medical illness requiring treatment during the study timeline
* Social, educational or economic hardship prohibitive to training schedule
* Concurrent enrollment in other cognitive training studies
* History of major psychiatric illness, including psychosis, bipolar disorder, alcohol or substance abuse, recent bereavement
* Score of 5 or more (i.e. presence of mild, moderate, or severe depression) on the Patient Health Screening Questionnaire (PHQ-9 Depression Screening); any participants reporting suicidal tendencies will be immediately referred to the site-specific Emergency Psychiatry Services (24-hour availability), and those with high depressive symptoms will be referred to their personal physician
* Current alcohol consumption that exceeds 14 drinks per week
* Illicit drug use
* Plans to travel out of the area for more than 1 week during the intervention period
* Residence too far from the testing site, which would prevent attending the testing sessions (\> 60 miles)
* Not being proficient enough in English that would prevent following and understanding all instructions and completing all testing sessions (typically, participants would need to have learned English before age 11; there might be some exceptions that will be decided on a case-by-case basis).
* Diagnosis of dementia or other neurological disease, including mild cognitive impairment (MCI)
* Score \< 26 (out of 30) on the Mini Mental State Exam (MMSE)
* Score \< 18 (out of 22) on the Telephone Montreal Cognitive Assessment (T-MoCA).
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aaron R. Seitz, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Riverside
Susanne M. Jaeggi, PhD
Role: PRINCIPAL_INVESTIGATOR
Northeastern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Riverside
Riverside, California, United States
Northeastern University
Boston, Massachusetts, United States
University of Wisconsin - Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aaron Seitz, PhD
Role: primary
Susanne Jaeggi, PhD
Role: primary
C. Shawn Green, PhD
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A487400
Identifier Type: OTHER
Identifier Source: secondary_id
2019-1378: R01
Identifier Type: -
Identifier Source: org_study_id